Adoptive T-cell therapy (ACT), infusion of autologous tumor-reactive T cells, can mediate complete clinical responses in some patients with B-cell malignancies and metastatic melanoma. 5–12 Study of ...

Regression of metastases was delayed, occurring a median of 129 days after transplantation, and often followed the withdrawal of cyclosporine and the establishment of complete donor–T-cell ...